Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 clinical trial in Kerkrade, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical investigation focusing on severe chronic kidney disease and its complications, evaluating potential therapeutic interventions for improving patient outcomes.
The study examines the effectiveness of dapagliflozin in patients with compromised renal function, including those on dialysis with residual diuresis and kidney transplant recipients.
Comprehensive research exploring the intersection of heart failure and kidney disease, investigating therapeutic approaches to reduce hospitalizations and improve patient care.
The trial focuses on measuring composite endpoints including kidney failure progression and cardiovascular events in vulnerable patient populations.
Specialized research examining outcomes in kidney transplant recipients, evaluating therapeutic interventions to protect graft function and prevent complications.
This research component specifically addresses the needs of transplant patients with particular attention to maintaining adequate renal function.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
